Compare APYX & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APYX | BTCS |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.0M | 75.4M |
| IPO Year | 1995 | 2008 |
| Metric | APYX | BTCS |
|---|---|---|
| Price | $3.62 | $1.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $6.50 | ★ $7.00 |
| AVG Volume (30 Days) | 84.5K | ★ 699.2K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.78% |
| EPS Growth | ★ 19.40 | N/A |
| EPS | N/A | ★ 1.48 |
| Revenue | N/A | ★ $4,073,518.00 |
| Revenue This Year | $9.36 | $248.05 |
| Revenue Next Year | $6.70 | $41.01 |
| P/E Ratio | ★ N/A | $1.22 |
| Revenue Growth | N/A | ★ 204.08 |
| 52 Week Low | $0.83 | $1.27 |
| 52 Week High | $4.50 | $8.49 |
| Indicator | APYX | BTCS |
|---|---|---|
| Relative Strength Index (RSI) | 51.56 | 44.56 |
| Support Level | $3.25 | $1.46 |
| Resistance Level | $4.40 | $1.97 |
| Average True Range (ATR) | 0.22 | 0.13 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 55.56 | 53.93 |
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.